ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Deborah M. Messemer sold $42K of Allogene Therapeutics, Inc.
Sold$42,488
$2.28Price
18,641Shares
−10%Stake
What ALLO did after the filing
- The stock from Thu, Jun 20 close, $2.44
- +5.3%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Aug 2 close.
Traded Tue, Jun 18. Filed Thu, Jun 20, 12:31 PM ET, during the session. Returns use the Jun 20 close and the Aug 2 close. Not investment advice.